Financing
Debt Issuance Proceeds
Guardant Health Debt Issuance Proceeds remained flat by 0.0% to $100.63M in Q4 2025 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ4 2025Feb 19, 2026
How to read this metric
An increase signals a decision to leverage the balance sheet to fund growth, while a decrease may indicate a focus on deleveraging.
Detailed definition
This represents the cash inflows from the issuance of long-term debt instruments, such as convertible notes or corporate...
Peer comparison
Common for companies seeking to extend their cash runway without further diluting shareholders.
Metric ID:
debt_issuanceHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $402.5M |
Range$0 – $402.5M
Debt Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Guardant Health's debt issuance proceeds?
- Guardant Health (GH) reported debt issuance proceeds of $100.63M in Q4 2025.
- What does debt issuance proceeds mean?
- Cash received from borrowing money through debt instruments.